NL-OMON54537招募中不适用
Interventions to curb hepatitis C reinfections among men who have sex with men. - ICECREAM study
GGD Amsterdam0 个研究点目标入组 246 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 246
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Men who have sex with men >= 18 years
- •- History of a prior HCV infection (succesfully treated or spontaneously
排除标准
- •- Acute or chronic HCV infection at time of enrolment (positive HCV RNA).
- •- Under HCV treatment at time of enrolment.
- •- Unlikely, in the opinion of the clinician, to comply with the study
- •procedures.
- •- Currently participating in an intervention study that offers extra HCV
- •testing and/or a behavioural intervention.
- •- Investigators and other dependent persons.
研究者
相似试验
招募中
不适用
Anti-viral therapy for recurrent hepatitis C after living donor liver transplantatioJPRN-UMIN000003286Kyoto University150
已完成
不适用
Retreatment of hepatitis C non-responsive to Interferon: a placebo controlled randomised trial of Ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the BeneluxChronic hepatitis CInfections and InfestationsHepatitisISRCTN53821378Schering Plough International (USA)117
进行中（未招募）
1 期
Four weeks treatment for chronic hepatitis C in patients under 50 years of age with no significant liver fibrosisEUCTR2017-005179-21-DKDepartment of infectious Diseases, Odense University Hospital227
进行中（未招募）
1 期
Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variantsPatients with chronic hepatitis CMedDRA version: 19.1Level: LLTClassification code 10074391Term: Chronic hepatitis C virus genotype 1System Organ Class: 100000004862EUCTR2015-001956-31-DKDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre.111
已完成
2 期
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17